Study of Optimal Treatment Plan in Hypertensives With Anti-AT1-Receptor Autoantibody

This study is currently recruiting participants.

Study NCT00360763 Information provided by Huazhong University of Science and Technology

First Received: August 4, 2006 No Changes Posted

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	December 2006
Estimated Primary Completion Date:	No date given

No publications provided by Huazhong University of Science and Technology

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Wei F, Jia XJ, Yu SQ, Gu Y, Wang L, Guo XM, Wang M, Zhu F, Cheng X, Wei YM, Zhou ZH, Fu M, Liao YH; SOT-AT1 Study Group. Candesartan versus imidapril in hypertension: a randomised study to assess effects of anti-AT1 receptor autoantibodies. Heart. 2011 Mar;97(6):479-84. Epub 2011 Feb 4.